{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T12:57:29Z","timestamp":1774443449840,"version":"3.50.1"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>This review focuses on acute kidney injury (AKI) associated with glomerular diseases and specifically the mechanisms of development of AKI in the wide spectrum of glomerulopathies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>The immune system and the kidneys are closely linked. In healthy individuals, the kidneys contribute to immune homeostasis, whereas components of the immune system mediate many acute forms of kidney disease. Both crescentic and noncrescentic forms of acute glomerulonephritis can present as AKI. The diagnosis of glomerular diseases underlying AKI requires a high degree of suspicion coupled with an algorithmic approach to laboratory investigations. Renal biopsy represents the gold standard for the diagnosis of medical conditions of the kidney. The main clinical\u2013biological presentations of glomerular diseases are acute nephritic syndrome, nephrotic syndrome and rapidly progressive glomerulonephritis (RPGN). All these presentations can be worsened by AKI both in the onset and in the clinical course. Heavy proteinuria and macroscopic hematuria can be directly involved in the development of AKI.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>AKI associated with glomerular diseases is not uncommon. Sometimes it represents an emergency case. The understanding of the various mechanisms underlying kidney diseases is improving, and may aid in their prevention and treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mcc.0000000000000675","type":"journal-article","created":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T20:58:25Z","timestamp":1572901105000},"page":"573-579","source":"Crossref","is-referenced-by-count":13,"title":["Acute kidney injury associated with glomerular diseases"],"prefix":"10.1097","volume":"25","author":[{"given":"Roberta","family":"Fenoglio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savino","family":"Sciascia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Baldovino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario","family":"Roccatello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230913","first-page":"85","article-title":"Acute kidney injury: definition, pathophysiology and clinical phenotypes","volume":"37","author":"Makris","year":"2016","journal-title":"Clin Biochem Rev"},{"key":"R2-20230913","first-page":"160","article-title":"Acute renal failure of glomerular origin","volume":"68","author":"Thervet","year":"2018","journal-title":"Rev Prat"},{"key":"R3-20230913","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1177\/0961203317751645","article-title":"Safety of outpatient percutaneous native renal biopsy in systemic autoimmune diseases: results from a monocentric cohort","volume":"27","author":"Roccatello","year":"2018","journal-title":"Lupus"},{"key":"R4-20230913","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.3390\/ijms20092205","article-title":"Glomerular hematuria: cause or consequence of renal inflammation?","volume":"20","author":"Moreno","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R5-20230913","doi-asserted-by":"crossref","first-page":"19732","DOI":"10.1038\/srep19732","article-title":"Haematuria on the Spanish Registry of Glomerulonephritis","volume":"6","author":"Yuste","year":"2016","journal-title":"Sci Rep"},{"key":"R6-20230913","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1056\/NEJMra1206793","article-title":"IgA nephropathy","volume":"368","author":"Wyatt","year":"2013","journal-title":"N Engl J Med"},{"key":"R7-20230913","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/ckj\/sfu100","article-title":"Focal and segmental glomerulosclerosis: clinical and kidney biopsy correlations","volume":"7","author":"Sethi","year":"2014","journal-title":"Clin Kidney J"},{"key":"R8-20230913","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2215\/CJN.04700513","article-title":"C3 glomerulopathy: clinicopathologic features and predictors of outcome","volume":"9","author":"Medjeral-Thomas","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"R9-20230913","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10157-017-1447-0","article-title":"Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120","volume":"22","author":"Schulman","year":"2018","journal-title":"Clin Exp Nephrol"},{"key":"R10-20230913","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/path.5011","article-title":"Podocytes are new cellular targets of haemoglobin-mediated renal damage","volume":"244","author":"Rubio-Navarro","year":"2018","journal-title":"J Pathol"},{"key":"R11-20230913","doi-asserted-by":"crossref","first-page":"23498","DOI":"10.1038\/srep23498","article-title":"Selection of urinary sediment miRNAs as specific biomarkers of IgA nephropathy","volume":"6","author":"Duan","year":"2016","journal-title":"Sci Rep"},{"key":"R12-20230913","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3109\/0886022X.2011.553301","article-title":"Acute kidney injury in adult idiopathic nephrotic syndrome","volume":"33","author":"Chen","year":"2011","journal-title":"Renal Fail"},{"key":"R13-20230913","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1093\/ndt\/gfu355","article-title":"Permeability factors in idiopathic nephrotic syndrome: historical perspectives and lessons for the future","volume":"29","author":"Maas","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"R14-20230913","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0272-6386(13)80001-7","article-title":"Reversible renal failure in the nephrotic syndrome","volume":"19","author":"Smith","year":"1992","journal-title":"Am J Kidney Dis"},{"key":"R15-20230913","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000381195","article-title":"Nephrosclerosis: a term in quest of a disease","volume":"129","author":"Meyrier","year":"2015","journal-title":"Nephron"},{"key":"R16-20230913","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.kint.2018.04.024","article-title":"Acute kidney injury complicating nephrotic syndrome of minimal change disease","volume":"94","author":"Meyrier","year":"2018","journal-title":"Kidney Int"},{"key":"R17-20230913","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/ndt\/16.2.221","article-title":"Pathophysiology of acute renal failure in idiopathic nephrotic syndrome","volume":"16","author":"Koomans","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"R18-20230913","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s12882-017-0756-6","article-title":"Unique proximal tubular cell injury and the development of acute kidney injury in adult patients with minimal change nephrotic syndrome","volume":"18","author":"Fujigaki","year":"2017","journal-title":"BMC Nephrol"},{"key":"R19-20230913","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s00108-019-0575-x","article-title":"Rapid progressive glomerulonephritis","volume":"60","author":"Haubitz","year":"2019","journal-title":"Internist (Berl)"},{"key":"R20-20230913","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/cei.13119","article-title":"The role of the immune system in kidney disease","volume":"192","author":"Tecklenborg","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"R21-20230913","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1055\/s-0038-1673386","article-title":"Pathogenesis of ANCA-associated pulmonary vasculitis","volume":"39","author":"Alba","year":"2018","journal-title":"Semin Respir Crit Care Med"},{"key":"R22-20230913","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nri3523","article-title":"The immune system and kidney disease: basic concepts and clinical implications","volume":"13","author":"Kurts","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"R23-20230913","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00393-016-0053-y","article-title":"Effector memory T-cells in the pathogenesis of ANCA-associated vasculitides","volume":"76","author":"Kerstein","year":"2017","journal-title":"Z Rheumatol"},{"key":"R24-20230913","first-page":"951","article-title":"Application of RIFLE criteria in Chinese patients with ANCA-associated renal vasculitis","volume":"29","author":"Chen","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"R25-20230913","first-page":"187","article-title":"Antineutrophil cytoplasmic antibodies-associated glomerulonephritis: from bench to bedside","volume":"4","author":"Chen","year":"2018","journal-title":"Chronic Dis Transl Med"},{"key":"R26-20230913","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1146\/annurev-immunol-032414-112220","article-title":"Macrophages: development and tissue specialization","volume":"33","author":"Varol","year":"2015","journal-title":"Annu Rev Immunol"},{"key":"R27-20230913","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2215\/CJN.03230314","article-title":"M2 macrophage infiltrates in the early stages of ANCA-associated pauci-immune necrotizing GN","volume":"10","author":"Zhao","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"R28-20230913","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/j.ajpath.2017.05.003","article-title":"Monocytes promote crescent formation in antimyeloperoxidase antibody-induced glomerulonephritis","volume":"187","author":"Rousselle","year":"2017","journal-title":"Am J Pathol"},{"key":"R29-20230913","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1093\/ndt\/gfv288","article-title":"Complement in ANCA-associated glomerulonephritis","volume":"32","author":"Hilhorst","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"R30-20230913","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/ndt\/gfn586","article-title":"Complement deposition in renal histopathology of patients with ANCA-associated pauci-immune glomerulonephritis","volume":"24","author":"Chen","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R31-20230913","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.kint.2015.12.003","article-title":"Diagnosis of complement alternative pathway disorders","volume":"89","author":"Angioi","year":"2016","journal-title":"Kidney Int"},{"key":"R32-20230913","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.kint.2018.11.008","article-title":"Management and treatment of glomerular diseases (Part 2): Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"95","author":"Rovin","year":"2019","journal-title":"Kidney Int"},{"key":"R33-20230913","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.2215\/CJN.00120115","article-title":"Association of serum C3 concentration and histologic signs of thrombotic microangiopathy with outcomes among patients with ANCA-associated renal vasculitis","volume":"10","author":"Manenti","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"R34-20230913","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/apm.12566","article-title":"Understanding the complement-mediated glomerular diseases: focus on membranoproliferative glomerulonephritis and C3 glomerulopathies","volume":"124","author":"Lionaki","year":"2016","journal-title":"APMIS"},{"key":"R35-20230913","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41581-018-0107-2","article-title":"C3 glomerulopathy understanding a rare complement-driven renal disease","volume":"15","author":"Smith","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"R36-20230913","doi-asserted-by":"crossref","first-page":"18005","DOI":"10.1038\/nrdp.2018.5","article-title":"Antiphospholipid syndrome","volume":"4","author":"Schreiber","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"R37-20230913","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41572-018-0009-4","article-title":"Cryoglobulinaemia","volume":"4","author":"Roccatello","year":"2018","journal-title":"Nat Rev Dis Primers"}],"container-title":["Current Opinion in Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCC.0000000000000675","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T19:37:41Z","timestamp":1694633861000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCC.0000000000000675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/mcc.0000000000000675","relation":{},"ISSN":["1070-5295","1531-7072"],"issn-type":[{"value":"1070-5295","type":"print"},{"value":"1531-7072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]}}}